Clinical trials: Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure
- Condition Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure
- Age group Children (under 18)
Prostate Cancer
Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure
This is a multi-centre, phase II, open-label, 12-month clinical trial for patients previously treated with WST09 (Tookad) who have positive prostate biopsies for cancer.
- Trial name
- NCT00305929
- Testing
- Treatment with Tookad VTP
- Where
- Canada
- Volunteers
- 8 people
- Sponsor
- STEBA France